Stocks Health care MEDS
NASDAQ · Health careDataMeds AI, Inc. (MEDS)
DataMeds AI, Inc. brought in $8M of revenue over the twelve months to June 30, 2026. It posted a net loss of $88.3M. At June 30, 2026 it held $2.5M in cash against $31.8M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 17, 2026.
Watch MEDS in 60 secondsWhat DataMeds AI, Inc. does
DataMeds AI, Inc. is registered with the SEC under industry code SIC 5122 (Wholesale-Drugs, Proprietaries & Druggists' Sundries). Its shares trade on NASDAQ under the ticker MEDS.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $23.3M | -$101.3M | -$1.43 | n/a |
| 2024 | $18.1M | -$6.9M | -$0.15 | n/a |
| 2024 | n/a | -$2.9M | -$0.06 | n/a |
Full financial statements: income, balance sheet and cash flow
Where MEDS ranks in Health care
Latest SEC filings
What DataMeds AI, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 17, 2026Other event 8-K
- September 16, 2026
- August 31, 2026Form PRE 14C filing PRE 14C
- August 18, 2026
- August 17, 2026Quarterly report 10-Q · period to June 30, 2026Revenue fell 77% to $1.8M versus the same quarter last year; diluted EPS -$7.13 versus -$5.40.
- August 14, 2026Other event 8-K
- August 14, 2026Late quarterly report notice NT 10-Q
- August 7, 2026IPO registration S-1
- August 4, 2026
- July 29, 2026Other event 8-K
Insider trades
What the people running DataMeds AI, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| June 22, 2026 | Patel PrashantChief Executive Officer, Director | Exercised options | 100,000 | $500 |
| June 22, 2026 | Ajjarapu Surendra KDirector | Exercised options | 100,000 | $500 |
| March 31, 2026 | Patel PrashantChief Executive Officer, Director | Received as pay | 5,000,000 | $1M |
| March 31, 2026 | Ajjarapu Surendra KDirector | Received as pay | 5,000,000 | $1M |
Who owns MEDS
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
Largest institutional holders
Insiders
2 insiders reported holding 540,010 shares in total, about $1.7M at the last price.
| Holder | Shares |
|---|---|
| Patel PrashantChief Executive Officer, Director | 282,365 |
| Ajjarapu Surendra KDirector | 257,645 |
Questions about MEDS
What does DataMeds AI, Inc. do?
DataMeds AI, Inc. is registered with the SEC under industry code SIC 5122 (Wholesale-Drugs, Proprietaries & Druggists' Sundries). Its shares trade on NASDAQ under the ticker MEDS.
Is DataMeds AI, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $88.3M on revenue of $8M.
How much revenue does DataMeds AI, Inc. make?
Over the twelve months to June 30, 2026 DataMeds AI, Inc. reported revenue of $8M.
When did DataMeds AI, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 17, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the other event from September 17, 2026.
Similar companies
Compare MEDS with
Follow MEDS
Get an email when DataMeds AI, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow MEDS: get an email when it filesWhere the numbers come from
Financial figures are the values DataMeds AI, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.